In some youths, frequent mood instability—sudden and unpredictable shifts in emotional states—may precede a "conversion" to bipolar disorder (BD). These sudden shifts in emotions can take various…
Read More
A follow-up study of young adults who were diagnosed years earlier with childhood-onset bipolar disorder suggests that their cognitive flexibility—in many cases already impaired at the time of…
Read More
On May 28th, the U.S. Food and Drug Administration (FDA) approved cariprazine for the treatment of depressive episodes in adults with bipolar I disorder. Sold under the brand name Vraylar, the…
Read More
Cariprazine, a medicine approved by the FDA in 2015 for the treatment of manic episodes in bipolar I disorder, was effective in reducing depressive symptoms in bipolar I disorder patients in a phase…
Read More
A multi-decade study focusing on children of parents diagnosed with bipolar disorder quantifies the risk—24.5%—that they themselves will develop bipolar illness, and suggests a “progressive sequence…
Read More
